Skip to main content
. Author manuscript; available in PMC: 2010 Apr 6.
Published in final edited form as: Eur J Pharmacol. 2000 Aug 18;402(1-2):69–76. doi: 10.1016/s0014-2999(00)00503-3

Fig. 5.

Fig. 5

Comparison of quadazocine and nor-BNI antagonism when they were administered s.c. in the tail and in the back against dynorphin A-(1–17)-induced local antiallodynia. The symbol “T” indicates the corresponding compound was administered s.c. in the tail. The symbol “B” indicates the corresponding antagonist was administered s.c. in the back. The symbol “−” represents the absence of conditions. See Materials and methods and Fig. 1 for other details.